The aggregated data suggested that high expression level of SNHG12 was significantly correlated to poor OS (HR = 1.97, 95%CI: 1.56–2.48, p < 0.001) (Figure 2(a)), indicating that lower SNHG12 expression in cancer patients may suggest a better survival outcome. Here, SNHG12 is linked to cancer.